Alpha Tau Medical Ltd. 是一家临床阶段的肿瘤治疗公司,在以色列和美国从事用于治疗实体癌的α发射放射治疗(Alpha DaRT)的研究、开发和商业化。公司总部位于以色列耶路撒冷。
财务指标
营业收入
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
营业支出
2026-06-30
$1378.2万
2026-03-31
$1331.3万
2025-12-31
$1260.2万
2025-09-30
$1073万
净利润
2026-06-30
-$4581.3万
2026-03-31
-$2293.9万
2025-12-31
-$1213.6万
2025-09-30
-$1168.6万
净利润率
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
每股收益
2026-06-30
$-0.50
2026-03-31
$-0.26
2025-12-31
$-0.14
2025-09-30
$-0.14
息税折旧摊销前利润
2026-06-30
-$1378.2万
2026-03-31
-$1331.3万
2025-12-31
-$1124.1万
2025-09-30
-$1073万
有效税率
2026-06-30
-0.5%
2026-03-31
0.04%
2025-12-31
0.28%
2025-09-30
0.06%
项目
2026-06-30
2026-03-31
2025-12-31
2025-09-30
营业收入
$0
$0
$0
$0
营业支出
$1378.2万
$1331.3万
$1260.2万
$1073万
净利润
-$4581.3万
-$2293.9万
-$1213.6万
-$1168.6万
净利润率
--
--
--
--
每股收益
$-0.50
$-0.26
$-0.14
$-0.14
息税折旧摊销前利润
-$1378.2万
-$1331.3万
-$1124.1万
-$1073万
有效税率
-0.5%
0.04%
0.28%
0.06%
常见问题
DRTS represents the ticker for a publicly traded company whose specific business operations are detailed on its stock page. The company operates within its designated industry, and its core activities directly influence financial performance. To understand what DRTS does, review the company profile and recent filings available on the page. This information helps investors assess the company's business model, revenue sources, and competitive position.
Recent performance for DRTS can be tracked through the latest price data on the page, which shows changes over various periods. Stock performance reflects market sentiment, company news, and broader economic trends. For the most accurate and current figures, refer to the live quote and historical chart provided. This data helps investors understand short-term momentum without relying on outdated information.
Evaluating DRTS valuation involves reviewing metrics such as price-to-earnings, price-to-sales, and price-to-book ratios, which are displayed on the page when available. Comparing these ratios to industry peers and the company's historical averages provides context. Additionally, assessing growth prospects and profitability can offer a more complete picture. Always ensure the data is current, as valuation changes with market conditions.
Trading of DRTS outside regular market hours depends on whether it is eligible for pre-market or after-hours sessions, which typically run from 4:00 a.m. to 9:30 a.m. and 4:00 p.m. to 8:00 p.m. ET. Not all brokers support extended-hours trading, and liquidity may be lower, leading to wider spreads. Check with your brokerage and review the trading information on the page for specific availability.
Key financial metrics for DRTS include revenue growth, net income, earnings per share, operating margin, and return on equity. These indicators reveal profitability, efficiency, and financial health. Cash flow from operations and debt levels also matter for assessing sustainability. Investors can find these figures in quarterly and annual reports, and compare them over time to identify trends.
Investing in DRTS carries risks such as market volatility, industry-specific challenges, and company execution risks. Economic downturns, competitive pressures, and regulatory changes can negatively impact performance. Additionally, small-cap or sector-focused stocks may experience lower liquidity and higher price swings. Reviewing risk factors in SEC filings and staying informed about company developments helps investors understand potential downside scenarios.